DOC earnings history

DOC FY2026 Q1 · Calendar Q2 2026

Healthpeak Properties, Inc.

Healthpeak's Q1 FY2026 results marked a decisive shift from the prior quarter's maintained guidance posture to a raised outlook, with adjusted FFO guidance lifted to $1.71-$1.75 per share. The company executed on multiple strategic fronts simultaneously: a $100M stock buyback at a 10%+ FFO yield, a $170M Blackstone joint-venture recap, and the Janus Living IPO that values its senior-housing FFO at a multiple roughly 20x higher than Healthpeak's own. Outpatient medical leasing remained strong with 5.4% cash re-leasing spreads on renewals, and management projected a 100-basis-point improvement in lab occupancy by year-end. The stock surged 18.1% on the report, a 16.7% abnormal move on 3.7x normal volume, reflecting the market's recognition of the earnings power unlocked through capital recycling and the Janus Living separation.